New Zealand markets closed
  • NZX 50

    11,641.85
    -12.71 (-0.11%)
     
  • NZD/USD

    0.6415
    +0.0041 (+0.64%)
     
  • NZD/EUR

    0.6082
    +0.0030 (+0.50%)
     
  • ALL ORDS

    7,503.50
    -50.50 (-0.67%)
     
  • ASX 200

    7,301.50
    -52.90 (-0.72%)
     
  • OIL

    80.34
    -0.88 (-1.08%)
     
  • GOLD

    1,797.30
    -3.80 (-0.21%)
     
  • NASDAQ

    11,994.26
    -47.63 (-0.40%)
     
  • FTSE

    7,556.23
    -2.26 (-0.03%)
     
  • Dow Jones

    34,429.88
    +34.87 (+0.10%)
     
  • DAX

    14,529.39
    +39.09 (+0.27%)
     
  • Hang Seng

    18,675.35
    -61.09 (-0.33%)
     
  • NIKKEI 225

    27,777.90
    -448.18 (-1.59%)
     
  • NZD/JPY

    86.1260
    -0.0390 (-0.05%)
     

Shore Capital Partners Announces Sale of EyeSouth Partners

CHICAGO, September 30, 2022--(BUSINESS WIRE)--Shore Capital Partners ("Shore" or "Shore Capital"), a Chicago-based private equity firm focused on microcap investing, is pleased to announce the sale of EyeSouth Partners ("EyeSouth"), an eye care management services organization committed to partnering with leading doctors, to Olympus Partners.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220930005141/en/

Shore formed EyeSouth in 2017 with the goal of creating a leading ophthalmology platform in the South and providing the highest level of support to its practices and clinicians. At the time of founding, Shore completed a strategic partnership with Georgia Eye Partners and its founding physician, Dr. Eugene Gabianelli, was appointed Chief Medical Officer of EyeSouth. Led by Chief Executive Officer Rex Adams, EyeSouth has grown its affiliate network from 5 locations to over 155 locations throughout Georgia, Texas, Louisiana, Florida, Tennessee, Ohio, Kentucky, Pennsylvania, Alabama, North Carolina and Illinois.

"We are extremely proud of what the EyeSouth team has built," said Justin Ishbia, Chairman of the EyeSouth Board and Founder and Managing Partner of Shore. "Through the company’s significant growth, the EyeSouth team remained committed to clinical quality and a patient-first culture above all else. With strong executive management in place under Rex’s leadership, we look forward to following EyeSouth’s continued growth as a leading national eye care provider."

"EyeSouth’s doctor ownership model and industry-leading support services have enabled the company to rapidly expand from 12 doctors at founding to over 270 doctors currently," said Chris Mioton, Member of the EyeSouth Board and Partner at Shore. "EyeSouth recently entered Illinois, its 11th state, and has experienced incredible momentum since the company’s creation five years ago. We wish the EyeSouth team continued success in their next chapter with Olympus."

"Shore’s partnership was invaluable and enabled us to expand rapidly," said Adams. "We were able to move faster with less risk, given Shore’s years of experience investing in healthcare businesses and deep bench of hands-on operational support typically only accessible to large-cap companies."

"Since starting Georgia Eye Partners in 1999, our primary focus has been providing top-quality clinical care, and I am delighted that we have maintained this since expanding and adding new affiliates to the EyeSouth platform," said Dr. Gabianelli. "We look forward to continuing to support physicians with resources that enable them to do their best work and provide exceptional care to their patients."

Rich Agabs, Atishay Chopra and Brian Castiglioni of Jefferies LLC are serving as exclusive financial advisor through their Essential Outpatient Healthcare franchise and Winston & Strawn LLP is serving as legal advisor to Shore and EyeSouth. Bass, Berry & Sims is serving as regulatory counsel to Shore and EyeSouth.

About Shore Capital Partners

Shore Capital Partners, a Chicago-based private equity firm with offices in Nashville, is focused on microcap investments within the Healthcare, Food and Beverage, Business Services and Real Estate industries. Shore supports management partners with capital, business development expertise and industry knowledge to accelerate growth, fund acquisitions and generate value for shareholders. Shore targets investments in proven, successful private companies with superior management teams, stable cash flow and significant growth potential, including organic growth and growth through industry consolidation. Shore has approximately $3 billion of cumulative capital commitments through various investment vehicles. For more information, please visit: www.shorecp.com.

About EyeSouth Partners

Headquartered in Atlanta, Georgia, EyeSouth Partners is an eye care management services organization committed to partnering with leading physicians to build a premier network of eye care services throughout the U.S. EyeSouth’s partner practices’ clinical mission is to provide high quality medical and surgical specialty eye care. EyeSouth supports its affiliated practices and physician partners with strategic guidance, administrative resources, operating expertise and capital with an absolute focus on clinical quality and a patient-first culture. EyeSouth’s affiliate network consists of over 270 doctors providing medical and surgical eye care services at over 155 locations throughout Georgia, Texas, Louisiana, Florida, Tennessee, Ohio, Kentucky, Pennsylvania, Alabama, North Carolina and Illinois. For more information about EyeSouth Partners, please visit: www.eyesouthpartners.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20220930005141/en/

Contacts

Shore Capital Partners
Allison Dorr, Edelman Smithfield
allison.dorr@edelmansmithfield.com